GC
CRTX

Guggenheim Capital’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Guggenheim Capital’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-31,683
Closed -$298K – 3339
2013
Q3 		$298K Buy
+31,683
New +$286K ﹤0.01% 2610

Other funds holding CRTX

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HA
Havens Advisors New York $39.3M AUM 80.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return

Guggenheim Capital's CRTX Position: Q4 2013 in Review

Guggenheim Capital sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q4 2013, closing a stake of 31,683 shares — an estimated $298K sold.

Guggenheim Capital first reported a position in CRTX in Q3 2013 and held it in 1 quarter. The position peaked at $298K in Q3 2013. 62 funds tracked by Wall St. Rank hold CRTX as of Q4 2013.

  • Guggenheim Capital reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q4 2013 after selling out during the quarter.
  • Guggenheim Capital sold 31,683 CORNERSTONE THERAPEUTICS INC shares in Q4 2013, an estimated $298K.
  • Guggenheim Capital first reported a position in CORNERSTONE THERAPEUTICS INC in Q3 2013 and held it in 1 quarter.
  • Guggenheim Capital's CORNERSTONE THERAPEUTICS INC position peaked at $298K in Q3 2013.
  • 62 funds tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q4 2013.

Based on Guggenheim Capital's 13F filing for Q4 2013, filed 14 Feb 2014.